Inhibition of mouse and human class 1 aldehyde dehydrogenase by 4-(N,N-dialkylamino)benzaldehyde compounds.
Russo
J E
JE
Department of Chemistry, Whitman College, Walla Walla, Washington 99362, USA.
D000081:Acetamides / Q000494:pharmacology; D000444:Aldehyde Dehydrogenase / Q000037:antagonists & inhibitors*; D000080924:Aldehyde Dehydrogenase 1 Family; D000818:Animals; D001547:Benzaldehydes / Q000494:pharmacology*; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D006801:Humans; D007527:Isoenzymes / Q000037:antagonists & inhibitors*; D007700:Kinetics; D051379:Mice; D011619:Psychotropic Drugs / Q000494:pharmacology; D050697:Retinal Dehydrogenase; D013329:Structure-Activity Relationship; D013379:Substrate Specificity; D010128:p-Aminoazobenzene / Q000031:analogs & derivatives / Q000494:pharmacology
D000081:Acetamides; D001547:Benzaldehydes; D004791:Enzyme Inhibitors; D007527:Isoenzymes; D011619:Psychotropic Drugs; C065122:1-(N-diphenylacetamido)-2-butanol; C007368:C.I. Solvent Yellow 56; D010128:p-Aminoazobenzene; D000080924:Aldehyde Dehydrogenase 1 Family; D000444:Aldehyde Dehydrogenase; C510223:ALDH1A1 protein, human; C515028:ALDH1A1 protein, mouse; D050697:Retinal Dehydrogenase